Support vital cancer research programs to improve the prevention, detection, and treatment of the most prevalent cancers in Asia.
Join Us in the Fight Against Cancer
and Double Your Impact!
1 Feb 2023 – 28 Feb 2023
Double Your Impact
Donate now to support cancer
research, drive discoveries, and
eliminate inequalities in access to
care and treatment for all.
Hugill & Ip will match your donation and double your impact of fighting cancer and provide a complimentary Will service with donations of HK$3,800
**Please note that the matching campaign is applicable for online donations only**
Did You Know?
Over 60% of the world’s new cancer cases and 70% of cancer-related deaths occur in developing countries, many of which are in Asia.
Without intervention, the number of new cases in Asia is projected to increase by over 70% by 2040.
9,503,710
Cancer cases in Asia
in 2020
58.3
of cancer death
in Asia
1 OUT
OF 2
Cancer cases
diagnosed in Asia
Most Common Cancer in Asia
Join Us
Asian Fund for Cancer Research (AFCR) is working to eliminate inequality and improve access to cancer care in Asia through funding life-saving discoveries for better, more affordable prevention, detection, and treatment.
Help us fight against cancer and improve the lives of countless people in our community.
Double Your Impact
Learn More & Take Action
Contributed by Hugill & Ip
- Medical Malpractice: Negligence Towards
Cancer Patients - Disability Discrimination and Cancer
- Early Withdrawal of MPF When Suffering
From Cancer - Medical Leave: Rights and Protections of
the Terminally Ill - Proper Estate Planning When Terminally Ill
- The Positive Impact of Corporate Social
Responsibility
AFCR is registered in Hong Kong with the Inland Revenue Department. Our file number with the Inland Revenue Department is 91/7750. AFCR has a Certificate of Incorporation number 994957 with Company Registry.